TipHub

₹80.07

▲ +0.25 +0.31%

As of 27 Jul 2026 · delayed

NSE Listed

Anuh Pharma Limited (ANUHPHR)

Volume: 27,797Avg Vol 1W: 28,936.6Avg Vol 1M: 37,588.652W Range:₹67₹100
NSE BSE www.anuhpharma.com AI Report
Key Ratios
Checked 1d ago
Market Cap₹808 Cr
Current Price₹80.07
Previous Close₹79.82
High / Low (52w)₹100 / ₹67
Volume27,797
Avg Vol (1W)28,936.6
Avg Vol (1M)37,588.6
Stock P/E68.39
Book Value₹35.14
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹776 Cr
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value₹5
EPS (TTM)₹1.17
P/B2.28
Debt / Equity—
50 DMA₹78.61
200 DMA₹78.82
Day change+0.31%
Price Chart
₹80.07▼ 19.17% · 1Y
₹99₹674.5L
2025-07-29
2026-07-27

20-day avg volume: 38K shares

Pros
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 68.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹138 Cr₹166 Cr₹160 Cr₹198 Cr₹186 Cr₹186 Cr₹197 Cr₹202 Cr
EBITDA₹12 Cr₹18 Cr₹14 Cr₹17 Cr₹11 Cr₹10 Cr₹18 Cr₹16 Cr
Net Profit₹10 Cr₹15 Cr₹10 Cr₹12 Cr₹8 Cr₹8 Cr₹13 Cr₹12 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹325 Cr₹311 Cr₹442 Cr₹492 Cr₹534 Cr₹659 Cr₹671 Cr₹776 Cr
EBITDA₹33 Cr₹20 Cr₹40 Cr₹40 Cr₹48 Cr₹79 Cr₹62 Cr₹55 Cr
Net Profit₹23 Cr₹14 Cr₹28 Cr₹31 Cr₹36 Cr₹60 Cr₹47 Cr₹41 Cr
EPS9.332.855.676.17.2211.989.454.1
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹240 Cr₹326 Cr₹333 Cr₹347 Cr₹405 Cr₹446 Cr₹507 Cr₹557 Cr
Total Liabilities₹76 Cr₹164 Cr₹142 Cr₹133 Cr₹164 Cr₹154 Cr₹181 Cr₹205 Cr
Equity₹165 Cr₹162 Cr₹191 Cr₹214 Cr₹241 Cr₹291 Cr₹326 Cr₹352 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-9 Cr₹38 Cr₹67 Cr₹32 Cr₹48 Cr₹10 Cr
Investing₹52 Cr₹-8 Cr₹-43 Cr₹1 Cr₹-20 Cr₹18 Cr
Financing₹-33 Cr₹-19 Cr₹-12 Cr₹-9 Cr₹-5 Cr₹-26 Cr
Free Cash Flow₹-9 Cr₹38 Cr₹67 Cr₹32 Cr₹48 Cr₹10 Cr
Shareholding
Promoter 71.8% Institutions 0.01% Public 28.19%
About Anuh Pharma Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.

www.anuhpharma.com ↗
Efficiency & Working Capital
ROCE17.2%
Interest Coverage57.5
Dividend Payout—
Debtor Days113 d
Inventory Days70 d
Payable Days89 d
Cash Conversion Cycle94 d
Working Capital Days183 d
Shareholding Details

As of 2026-06-30

Promoter71.8%
FII0%
DII0%
Institutions0%
Public28.2%
Promoter Pledge0%
No. of Shareholders27,484
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Jul 2025Jul 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters69.9%69.9%69.9%69.9%69.9%69.9%69.9%69.9%71.8%71.8%71.8%71.8%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0.1%0%0%0%0%0%0%0%0%0%0%0%
Public29.9%30.1%30.1%30.1%30%30%30.1%30.1%28.2%28.2%28.2%28.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders22,23723,49423,91024,27924,23524,25726,15726,15728,25027,88927,42527,484
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Bharti Bipin ShahShareholding of Promoter and Promoter Group19.4%1.95 Cr
Prafulla Lalit ShahShareholding of Promoter and Promoter Group14.5%1.45 Cr
Bipin Nemchand ShahShareholding of Promoter and Promoter Group8.5%84,94,200
Bipin Nemchand ShahShareholding of Promoter and Promoter Group6.2%62,21,720
Bharat Nemchand ShahShareholding of Promoter and Promoter Group3.7%37,34,214
Gaurav Satish ShahShareholding of Promoter and Promoter Group3.2%32,00,688
Vivek Bipin ShahShareholding of Promoter and Promoter Group2.3%23,40,000
Mrudula Jayantilal ShahShareholding of Promoter and Promoter Group2.3%23,39,856
Ritesh Bipin ShahShareholding of Promoter and Promoter Group2.3%23,10,808
Dina Satish ShahShareholding of Promoter and Promoter Group2.2%22,20,280
Samir Jayantilal ShahShareholding of Promoter and Promoter Group1.7%17,25,004
Michael DsouzaPublic Shareholding1.1%10,98,000
Kinjal Siddharth JhaveriShareholding of Promoter and Promoter Group0.8%8,16,160
Jasmine Samir ShahShareholding of Promoter and Promoter Group0.7%6,64,560
Neeta Ketan ShahShareholding of Promoter and Promoter Group0.5%5,20,000
Harshit Bharat ShahShareholding of Promoter and Promoter Group0.5%4,96,988
Ketan Lalit ShahShareholding of Promoter and Promoter Group0.5%4,79,000
Praful Kantilal ShahShareholding of Promoter and Promoter Group0.5%4,60,664
Dhanishta Ritesh ShahShareholding of Promoter and Promoter Group0.4%3,60,000
Hemruchi Vivek ShahShareholding of Promoter and Promoter Group0.4%3,60,000
Surekha Bharat ShahShareholding of Promoter and Promoter Group0.3%2,67,344
Panna Mahesh ShahShareholding of Promoter and Promoter Group0.2%2,00,000
Japosha Trading LlpShareholding of Promoter and Promoter Group0.2%1,91,688
Mahesh Kantilal ShahShareholding of Promoter and Promoter Group0.2%1,68,010
Mrudula Praful ShahShareholding of Promoter and Promoter Group0.1%1,18,200
Board of Directors
NameDesignationYear
Arun TodarwalChairman & Non Executive Dir.2025
Bipin N ShahVice Chairman (Non-executive)2025
Ritesh B ShahJoint MD & Executive Director2025
Vivek B ShahJoint MD & Executive Director2025
Bharat N ShahNon Executive Director2025
Samir J ShahNon Executive Director2025
Ketan L ShahNon Executive Director2025
Gaurav ShahNon Executive Director2025
Harmanbhai Tulsibhai PatelIndependent Non Exe. Director2025
Mita DixitIndependent Non Exe. Director2025
Siddharth ShahIndependent Director2025
Pradeep ThakurIndependent Director2025
Manan Jayesh VadhanCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Bulk Drugs & Chemicals₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹5515050
Corporate Actions
TypeDateValueRemark
dividend2026-08-05₹1.5 (30%)Final
forthcoming2026-08-05Dividend (1.5/- per share)Final
dividend2025-08-14₹1.5 (30%)Final
bonus2025-07-151:11:1 Bonus Issue of Equity Shares
forthcoming—Book ClosureAGM & 30% Final Dividend
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000497101
2026000000
202600042933
Insider / Designated-Person Trades

4 recent disclosure(s)

BIJAL KAUSHAL SHROFFDisposal · 3,579
BIJAL KAUSHAL SHROFF RevisedDisposal · 2,521
BIJAL KAUSHAL SHROFFDisposal · 2,521
ROHAN MAHESH SHAHDisposal · 10,000
Substantial Acquisitions (SAST)

2 disclosure(s)

Market30/08/2024 · 3,579
Market29/08/2024 · 2,521
Company Information
Incorporated1960
ChairmanArun Todarwal
AuditorJayantilal Thakkar & Co
Investor Email[email protected]
🌐 www.anuhpharma.com ↗

📍 3-A Shivsagar Estate, North Wing Dr A B Road Worli, Mumbai, Maharashtra, 400018

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Annapurna Swadisht Ltd.Anondita Medicare LimitedAnsal Properties & Infrastructure Ltd.Antelopus Selan Enrgy Ltd.Antarctica Ltd.Anthem Biosciences Ltd.The Anup Engineering Ltd.Anupam Rasayan India Ltd.Anya Polytech & Fertilizers Ltd.Anzen India Energy Yield Plus TrustApar Industries Ltd.Anjani Portland Cement Ltd.All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search